Eli Lilly and the $1 Trillion Appetite (LLY)
Eli Lilly consensus check: 65x forward earnings multiple, Medicare drug pricing reforms, and GLP-1 manufacturing capacity bounds.
GLP-1
Eli Lilly consensus check: 65x forward earnings multiple, Medicare drug pricing reforms, and GLP-1 manufacturing capacity bounds.